Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abbott LaboratoriesXSWX:ABT +0.61%80 EV-to-OCF is 21.85 as of Jul. 24, 2026, which is 8% below its 10-year median of 23.67. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF106.75. Among 853 Medical Devices & Instruments companies, Abbott Laboratories ranks worse than 78.08% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Abbott Laboratories's Enterprise Value is CHF165,211 Mil.
Abbott Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was CHF7,560 Mil. Therefore, Abbott Laboratories's EV-to-OCF for today is 21.85.
The historical rank and industry rank for Abbott Laboratories's EV-to-OCF or its related term are showing as below:
XSWX:ABT'
s EV-to-OCF Range Over the Past 10 Years
Min: 16.89 Med: 23.67 Max: 33.53
Current: 21.4
During the past 13 years, the highest EV-to-OCF of Abbott Laboratories was 33.53. The lowest was 16.89. And the median was 23.67.
XSWX:ABT's EV-to-OCF is ranked worse than 78.08% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.94
vs XSWX:ABT: 21.40
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Abbott Laboratories's PE Ratio (TTM) for today is calculated as:
Abbott Laboratories's share price for today is CHF82.50.
Abbott Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.457.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Abbott Laboratories EV-to-OCF Related Terms
Abbott Laboratories EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's EV-to-OCF falls into.
Abbott Laboratories's current Enterprise Value is CHF165,211 Mil.
Abbott Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF7,560 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (XSWX:ABT) has a EV-to-OCF of 21.85 as of Jul. 24, 2026. This is near median its historical median of 23.67. Over the past decade, Abbott Laboratories' EV-to-OCF has ranged from 16.89 to 33.53. According to the industry distribution chart, Abbott Laboratories ranks #666 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 78.1%.
Is Abbott Laboratories' EV-to-OCF too high?
Abbott Laboratories' current EV-to-OCF of 21.85 is near median its 10-year median of 23.67. Over the past 10 years, this metric has ranged from a low of 16.89 to a high of 33.53. The Medical Devices & Instruments industry median EV-to-OCF is 7.94. Abbott Laboratories' value of 21.85 is 175.2% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #666 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' EV-to-OCF compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #666 out of 853 companies for EV-to-OCF. This places Abbott Laboratories in the lower half of its industry. The industry median EV-to-OCF is 7.94. Abbott Laboratories' value of 21.85 is 175.2% above this benchmark. Historically, Abbott Laboratories' own EV-to-OCF has ranged from 16.89 to 33.53 over the past decade. While the company's 10-year median is 23.67 vs. the industry median of 7.94, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.94, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current EV-to-OCF of 21.85 is 175.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current EV-to-OCF is 21.85, which is near median its own 10-year median of 23.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current EV-to-OCF of 21.85. The stock's GF Value™ is CHF106.75, compared to a current price of CHF82.50 — trading 22.7% below its estimated fair value. The current EV-to-OCF is 21.85, which is near median its 10-year median of 23.67 and 175.2% above the Medical Devices & Instruments industry median of 7.94. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current EV-to-OCF is 21.85 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of CHF82.50 is trading 22.7% below its estimated GF Value™ of CHF106.75.
Key valuation signals for XSWX:ABT:
EV-to-OCF: 21.85 (near median its 10-year median of 23.67)
GF Value™: CHF106.75 vs. price of CHF82.50 (22.7% below fair value)
Industry Position: 175.2% above the Medical Devices & Instruments median (#666 of 853)
No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for XSWX:ABT
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ABT has been successfully added to your 
